Thinking through postoperative cognitive dysfunction:How to bridge the gap between clinical and pre-clinical perspectives by Hovens, Iris B. et al.
  
 University of Groningen
Thinking through postoperative cognitive dysfunction
Hovens, Iris B.; Schoemaker, Regien G.; van der Zee, Eddy A.; Heineman, Erik; Izaks,
Gerbrand J.; van Leeuwen, Barbara L.
Published in:
Brain behavior and immunity
DOI:
10.1016/j.bbi.2012.06.004
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Hovens, I. B., Schoemaker, R. G., van der Zee, E. A., Heineman, E., Izaks, G. J., & van Leeuwen, B. L.
(2012). Thinking through postoperative cognitive dysfunction: How to bridge the gap between clinical and
pre-clinical perspectives. Brain behavior and immunity, 26(7), 1169-1179.
https://doi.org/10.1016/j.bbi.2012.06.004
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Brain, Behavior, and Immunity 26 (2012) 1169–1179Contents lists available at SciVerse ScienceDirect
Brain, Behavior, and Immunity
journal homepage: www.elsevier .com/locate /ybrbiThinking through postoperative cognitive dysfunction: How to bridge the gap
between clinical and pre-clinical perspectives
Iris B. Hovens a,b,⇑, Regien G. Schoemaker a, Eddy A. van der Zee a, Erik Heineman b,
Gerbrand J. Izaks c,d, Barbara L. van Leeuwen b
aDepartment of Molecular Neurobiology, University of Groningen, Groningen, The Netherlands
bDepartment of Surgery and Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
cUniversity Center for Geriatric Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
dAlzheimer Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
a r t i c l e i n f o a b s t r a c tArticle history:
Received 4 April 2012
Received in revised form 10 June 2012
Accepted 11 June 2012









Translational research0889-1591/$ - see front matter  2012 Elsevier Inc. A
http://dx.doi.org/10.1016/j.bbi.2012.06.004
⇑ Corresponding author at: Department of Molecula
Groningen, Nijenborgh 7, 9747 AG Groningen, The N
2357; fax: +31 50 363 2331.
E-mail address: I.B.Hovens@rug.nl (I.B. Hovens).Following surgery, patients may experience cognitive decline, which can seriously reduce quality of life.
This postoperative cognitive dysfunction (POCD) is mainly seen in the elderly and is thought to be med-
iated by surgery-induced inﬂammatory reactions. Clinical studies tend to deﬁne POCD as a persisting,
generalised decline in cognition, without specifying which cognitive functions are impaired. Pre-clinical
research mainly describes early hippocampal dysfunction as a consequence of surgery-induced neuroin-
ﬂammation. These different approaches to study POCD impede translation between clinical and pre-
clinical research outcomes and may hamper the development of appropriate interventions.
This article analyses which cognitive domains deteriorate after surgery and which brain areas might be
involved. The most important outcomes are: (1) POCD encompasses a wide range of cognitive impair-
ments; (2) POCD affects larger areas of the brain; and (3) individual variation in the vulnerability of neu-
ronal networks to neuroinﬂammatory mechanisms may determine if and how POCD manifests itself.
We argue that, for pre-clinical and clinical research of POCD to advance, the effects of surgery on var-
ious cognitive functions and brain areas should be studied. Moreover, in addition to general characteris-
tics, research should take inter-relationships between cognitive complaints and physical and mental
characteristics into account.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Old age comes with inﬁrmities, many of which can be success-
fully treated with surgery. Unfortunately, persistent cognitive
impairments can develop as a side-effect of these surgical proce-
dures, a phenomenon that is predominantly seen in the elderly
(Krenk et al., 2010; Rasmussen, 2006). This complication has been
termed ‘postoperative cognitive dysfunction’ (POCD). Surgery-in-
duced cognitive decline leads to an increased risk of disability
and mortality (Price et al., 2008; Steinmetz et al., 2009). As a con-
sequence, patients can lose their employment or independence,
which seriously reduces their quality of life (Dijkstra and Jolles,
2002; Monk et al., 2008; Price et al., 2008; Steinmetz et al.,
2009). In view of the growing number of elderly, POCD constitutes
not only a burden at the individual level, but also for society as a
whole (United Nations, 2010).ll rights reserved.
r Neurobiology, University of
etherlands. Tel.: +31 50 363There is currently no adequate treatment for POCD. Several ani-
mal models have been developed to study the underlying mecha-
nisms and to ﬁnd potential targets to treat or prevent cognitive
impairments after surgery. However, it can be questioned whether
the outcomes of these pre-clinical studies can be translated into
clinical practise. In this review article, a critical comparison is
made between the current clinical and pre-clinical views on POCD
to indicate the translational gaps between these research ﬁelds.
Based on an analysis of the cognitive domains and brain areas in-
volved in this condition, suggestions are made to improve research
on POCD.
2. Deﬁnition
In clinical studies of cognitive changes after surgery a distinc-
tion is made between delirium and POCD. Delirium is characterised
as an acute and transient disturbance of mental functions that may
be accompanied by changes in awareness (Funder et al., 2010;
Krenk et al., 2010). POCD encompasses more subtle cognitive
changes that are long lasting (Krenk et al., 2010). A second distinc-
tion that has been made is the occurrence of cognitive impairments
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cur muchmore frequently after cardiac surgery (Rasmussen, 2006).
It can be questioned whether these distinctions are relevant in
terms of underlying pathology or if they are just different manifes-
tations of one and the same process. Persistence of delirium symp-
toms, for example, has been reported several times (National
Clinical Guideline Centre, 2010). For the purpose of this review,
however, we will limit our deﬁnition of POCD to persistent cogni-
tive impairments after non-cardiac surgery. We consider cognitive
impairments to be persistent when they last for more than one
week after surgery, in contrast to early declines in cognition, which
occur within the ﬁrst week.3. Current views on POCD
Research into POCD can be divided into two distinct ﬁelds. Clin-
ical research has mainly focused on determining the prevalence,
risk factors and consequences of POCD. Conversely, pre-clinical
studies have mainly investigated the mechanisms underlying
POCD. Interestingly, these two ﬁelds seem to have developed in
different directions.3.1. The clinical perspective: diagnosis, incidence rate and risk factors
As early as 1955, Bedford described the occurrence of persistent
cognitive impairments after non-cardiac surgery (Bedford, 1955).
In the decades that followed, many studies were devoted to prov-
ing that this phenomenon indeed existed, but with limited results
(Dijkstra and Jolles, 2002; Newman et al., 2007). During the same
period, cognitive decline after cardiac surgery was proven
(Newman et al., 2007). The difﬁculties of verifying POCD after
non-cardiac surgery can be ascribed, on the one hand, to the rela-
tively low incidence and, on the other hand, a lack of consensus
regarding the deﬁnition of POCD and the use of insensitive test bat-
teries (Rasmussen et al., 2001; Dijkstra and Jolles, 2002; Funder
et al., 2010).
A change came in the mid-1990s when researchers started to
deﬁne POCD as a decline in performance on at least two or three
tests in a sensitive test battery following surgery (Moller et al.,
1998; Steinmetz et al., 2009; Williams-Russo et al., 1995). Using
this method, persistent cognitive decline could be demonstrated
after non-cardiac surgery, although reported incidences of POCD
still vary substantially, depending on the patient population, time
of measurement and the neuropsychological tests used (Deiner
and Silverstein, 2009; Rasmussen, 2006). In the International Study
of POCD, which included more than 1.200 patients, a 10% incidence
of POCD was observed in the elderly three months after surgery
(Monk et al., 2008). In addition, risk factors for POCD, such as
advancing age, the severity of surgery, the duration of anaesthesia,
the occurrence of complications, pre-existing cognitive impair-
ments and the level of education, have been determined (Moller
et al., 1998; Monk et al., 2008; Price et al., 2008). As a consequence
of these developments, clinical research usually deﬁnes POCD as
persistent cognitive decline in one or more cognitive domains,
without specifying what these domains are.
The cognitive domains that are said to be affected by surgery
are memory, attention and information processing (Dijkstra and
Jolles, 2002; Hanning, 2005; Krenk et al., 2010; Terrando et al.,
2011). It is, however, unclear on what evidence this statement is
based, since a detailed analysis of the neuropsychological test out-
comes of patients with POCD has not yet been performed. To our
knowledge, until now only four studies have made distinctions be-
tween the cognitive domains affected after surgery (Ancelin et al.,
2001; Bekker et al., 2010; Hudetz et al., 2011; Price et al., 2008). Of
these studies, only Hudetz et al. (2011) discussed, in more detail,which functions and brain structures might be involved in POCD.
Postoperative impairments were found in both executive function
and recent memory, but were most pronounced in the latter
modality. The authors noted that this might point towards involve-
ment of several temporal and prefrontal brain structures. However,
this study speciﬁcally focussed on patients with metabolic syn-
drome, so the results cannot be generalised to all patient catego-
ries. In addition, only tests of recent memory and executive
functions were included in this study, so it remains uncertain what
other cognitive functions are vulnerable to postoperative decline.
In conclusion, clinical research has led to a deﬁnition of POCD
which facilitates diagnosis and determination of the incidence rate
and risk factors of this condition, while an analysis of the symp-
toms has been overlooked.
3.2. The pre-clinical perspective; mechanism
Several mechanisms have been proposed to be involved in the
development of cognitive impairments after surgery, including
changes in cerebral blood ﬂow, sleep disturbances, effects of anaes-
thetics, and inﬂammation. Hypoperfusion, hypoxia and the forma-
tion of micro-emboli have been shown to occur during and after
surgery, and could potentially cause ischaemic brain damage, but
a clear relationship with POCD has not been found (Krenk et al.,
2010). Sleep disturbances can occur after surgery or due to the
use of medication, such as opioids, and are known to affect cogni-
tive performance (Krenk et al., 2010), but research on the inﬂuence
of such disturbances on POCD is scarce and inconclusive (Gögenur,
2010). Some types of anaesthesia have been shown to cause
neurodegenerative changes in animal studies (Culley et al., 2004;
Kalenka et al., 2010; Papaioannou et al., 2005). However, numerous
studies investigating the relationship between POCD and anaesthe-
sia have consistently failed to ﬁnd a relationship (Cao et al., 2010;
Cibelli et al., 2010; Krenk et al., 2010; Newman et al., 2007;
Rosczyk et al., 2008).
Consistent evidence is accumulating only for the role of inﬂam-
matory processes arising due to surgical trauma and subsequent
complications. Where clinical studies have provided leads to the
understanding of this mechanism, most of the studies researching
the mechanism in more detail have been performed using animal
models. Although low levels of immune activation are necessary
for regulating normal cognitive functions, the high levels of pro-
inﬂammatory factors associated with trauma or infection, have
been shown to detrimentally affect cognitive processes (Yirmiya
and Goshen, 2011). In patient studies, it was shown that tissue
damage associated with surgery activates the peripheral innate
immune system, leading to the release of inﬂammatory mediators
such as cytokines, reactive oxygen species and endothelins
(Giannoudis et al., 2006; Karlidag et al., 2006; Levy and Tanaka,
2003). These increases in peripheral levels of inﬂammatory factors
after surgery, such as IL-6 and IL-1b, have been related to a decline
in cognitive performance (Beloosesky et al., 2007; Cibelli et al.,
2010; Ramlawi et al., 2006; Yaffe et al., 2003). More evidence
comes from the ﬁnding that the risk of cognitive decline increases
with increased surgical severity and the occurrence of complica-
tions, as both of these factors are related to a higher magnitude
of the inﬂammatory response (Cibelli et al., 2010; Krenk et al.,
2010; Maze et al., 2008; Xie et al., 2009; Zakzanis et al., 2005). In
accordance with these ﬁndings, a study by Fidalgo et al. (2011a)
showed that sub-clinical inﬂammation following administration
of lipopolysaccharide substantially increased IL-1b plasma levels
and cognitive deterioration after surgery.
Once released into the systemic circulation, inﬂammatory
mediators can exert effects in the central nervous system (CNS)
via several routes. First, cytokines, such as IL-1, IL-6 and TNFa,
can cross the blood brain barrier (BBB) through the relatively
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et al., 2007; Dilger and Johnson, 2008). Second, cytokines can bind
to receptors on the endothelial cells of the BBB, which leads to the
secretion of inﬂammatory factors in the CNS (Dilger and Johnson,
2008). Finally, vagal afferent nerves can rapidly activate central
inﬂammatory pathways, when stimulated by immune factors in
the periphery (Dilger and Johnson, 2008; Maier, 2003). All of these
pathways together lead to activation of microglia in the CNS,
which, in turn, produce cytokines, reactive oxygen species and
other inﬂammatory factors (Lucin and Wyss-Coray, 2009; Schie-
pers et al., 2005). In accordance with these ﬁndings surgery was
associated with microglia activation that lasted up to three days
after surgery (Cao et al., 2010; Cibelli et al., 2010; Wan et al.,
2007), as well as hippocampal increases in the expression of IL-
1b and IL-6 (Cao et al., 2010; Cibelli et al., 2010; Fidalgo et al.,
2011a, 2011b; Rosczyk et al., 2008; Tan et al., 2010; Wan et al.,
2010).
Elevated cytokine levels are thought to inﬂuence neuronal pro-
cesses either directly or through interactions with neurotrophins
and neurotransmitter systems (Yirmiya and Goshen, 2011). Fidalgo
et al. (2011b), for example, showed that increases in hippocampal
IL-1b after orthopaedic surgery coincided with a reduction in
brain-derived neurotrophic factor. Furthermore, as illustrated by
Tan et al. (2010), increased cytokine levels after surgery may cause
tau hyper-phosphorylation and the formation of the neuroﬁbrillary
tangles associated with Alzheimer’s disease. Whether these
changes are serious enough to elicit neurodegeneration, or cause
a more subtle change in neuronal function, remains to be
determined.
The hippocampus seems especially vulnerable to the inﬂamma-
tion-mediated changes described above (Yirmiya and Goshen,
2011). Consequently, pre-clinical studies have mainly focused on
the role of inﬂammation in the surgery-induced decline of hippo-
campal function. These studies have used contextual fear memory
(Cibelli et al., 2010; Terrando et al., 2010; Fidalgo et al., 2011a,
2011b), spatial learning (Wan et al., 2007, 2010; Tan et al., 2010;
Wuri et al., 2011) or reversal learning (Rosczyk et al., 2008; Cao
et al., 2010) to demonstrate post-surgical impairment in hippo-
campus-mediated cognition that coincided with hippocampal
inﬂammatory changes. Only Cibelli et al. (2010) investigated the
effect of surgery on non-hippocampal memory, measured using
auditory fear conditioning. They did not ﬁnd any differences be-
tween animals that underwent surgery or animals that served as
control. These results are consistent with previous studies that
showed a negative inﬂuence of pro-inﬂammatory cytokines on
contextual, but not auditory-cued, fear conditioning (Yirmiya and
Goshen, 2011).
In line with most research on cytokine-induced cognitive
changes, pre-clinical studies tend to investigate cognitive decline
early after surgery and in young animals (Cao et al., 2010; Cibelli
et al., 2010; Fidalgo et al., 2011a; Terrando et al., 2010; Wan
et al., 2007). In these studies, cognitive and inﬂammatory changes
seem to recede within one week after surgery, making it question-
able whether the results truly reﬂect the persisting cognitive
impairments of POCD in the elderly.
In conclusion, pre-clinical research has led to animal models, in
which inﬂammatory mechanisms can indeed be related to reduced
cognitive performance after surgery, but whether these models
represent the speciﬁc characteristics of POCD in humans remains
unclear.4. Translational gap in POCD research
Summarizing the above, it can be said that whereas clinical re-
search tends to deﬁne POCD as a persisting generalised decline incognitive functions, pre-clinical research mainly describes early
inﬂammation-induced hippocampal dysfunction after surgery.
This has led to a translational gap in the research on POCD which
might lead to incomplete or incorrect assumptions about the
underlying mechanisms and, as such, seriously hamper the devel-
opment of appropriate therapies.
The translation of clinical ﬁndings to an animal model is hin-
dered by the lack of a detailed analysis of the cognitive functions
that deteriorate after surgery, since the rationale on which to base
pre-clinical models for POCD is lacking. Moreover, by overlooking
the type of cognitive decline after surgery, information is lost that
could be used to gain insight into the underlying mechanisms.
At the same time, the absence of an animal model that includes
all aspects of POCD impedes the translation of pre-clinical ﬁndings
to the clinical setting. Even though, for example, POCD is consid-
ered a condition that persists for weeks or months after surgery,
thus far only two animal studies (Fidalgo et al., 2011b; Wuri
et al., 2011) have investigated persisting cognitive impairment
after surgery. Only when consistency between clinical and pre-
clinical research exists, can the mechanisms underlying POCD be
truly understood and appropriate therapies developed.5. Bridging the translational gap
In view of the fact that adequate therapeutic strategies against
POCD need to be developed, the discrepancies between clinical and
pre-clinical research in this ﬁeld should be overcome. As noted
above, the rationale for a good pre-clinical model of POCD is ham-
pered by the lack of knowledge of the speciﬁc cognitive functions
that deteriorate after surgery. The translation from the clinical to
pre-clinical setting could be aided by analysing which cognitive
functions deteriorate after surgery and which brain areas are in-
volved in this deterioration. To this end, we performed two sys-
tematic searches (Supplementary data 1 and 2). First, we
reviewed and analysed the clinical literature to determine which
neuropsychological tests were used to study POCD (patient charac-
teristics and methods used are presented in Tables 1 and 2 respec-
tively) and which speciﬁc cognitive domains are affected in POCD
(Table 3). Second, we investigated which brain areas are involved
(Table 4). Based on these reviews we investigated the role of
individual variation in the development of POCD.5.1. Cognitive functions affected in POCD
The early and late decline in test performances of patients after
surgery (Table 3) follow a similar pattern, although cognitive
impairments are reported in a higher percentage of patients early
after surgery. This might reﬂect the presence of delirium or delir-
ium-related symptoms early after surgery. Memory functions,
especially visual and verbal recall, seem to be affected in the high-
est number of patients. Price et al. (2008) and Hudetz et al. (2011)
already noted this, based on the outcomes of their separate studies.
Language and visuospatial processing also decline in a relatively
large percentage of patients after surgery, with up to 15% of pa-
tients experiencing a decline in performance.
The cognitive functions that constitute the attention domain are
affected in a smaller percentage of patients. It is therefore possible
that this reported decline in attention is a consequence of natural
variation in test performance. However, the attention impairments
are consistently present in a number of tests and studies. Further-
more, concentration problems are frequently mentioned by pa-
tients after surgery (Debess et al., 2009; Dijkstra and Jolles, 2002;
Jones et al., 1990). It has been argued that cognitive complaints
after surgery do not correlate well with objective measurements
of POCD (e.g. neuropsychological test outcomes). These complaints
Table 1
Systematic review of postoperative decline after non-cardiac surgery in humans: patient characteristics.
Author Patients/controls (n) % Male Age (yrs.) Type of surgery
Williams-Russo et al. (1995) 262 30 >40 Total knee
Grichnik et al. (1999) 29 65.5 35–85 Thoracic and vascular
Ancelin et al. (2001) 140 33 64–87 Orthopaedic
Iohom et al. (2004) 40/13 55 40–84 Cholecystectomy
Rodriguez et al. (2005) 29 46 45–82 Total knee
Silverstein et al. (2007) 1185 (74 PCI)/176 54 >60 Major surgery
Price et al. (2008) 334/62 57 >60 Major surgery
Steinmetz et al. (2009) 701 43 >40 Mixed surgery
Steinmetz et al. (2010) 70 37 61–83 Mixed surgery
Hudetz et al. (2011) 60 (30 METS) 0 P55 Mixed surgery
Evered et al. (2011) 664 /34 61 >50 Total hip
PCI = pre-operative cognitive impairment; METS = metabolic syndrome; total knee = total knee arthroplasty; total hip = total hip joint replacement.
Table 2
Systematic review of postoperative decline after non-cardiac surgery in humans: methodology and incidence.
Author Pre-
op






Attention (2) Information (I & L1, 2)














Memory (13–15) Attention (4)
Information (L3,4 & V2,3)
Decline > 1SD 1 or more
scores





Memory (8) Attention (1,2)
Information (I & L1)







Memory (6,11) Attention (1,2)
Information (V1& L1,2)
Decline of > 0.5 SD






Memory (7) Attention (1,3)
Information (I)
2 Z scores or combined Z
score > 1.96
19% PCI 26% no PCI 15% PCI 10% no PCI
Price et al., 2008 Yes 7 days
3 months
Memory (7) Attention (1,3)
Information (I)










Memory (7) Attention (1,3)
Information (I)





Yes 7 days Memory (7) Attention (1,3)
Information (I)





Yes 1 month Memory (3,4, 5,10,11,12) Attention
(1) Information (L2)
2 Z scores or combined Z
score < - 1.96
- 43% METS 27% no METS
Evered et al., 2011 Yes 7 days
3 months
Memory (7) Attention (1,3)
Information processing (I)
2 RCI scores or combined
Z score < - 1.96
17% 16%
The tests are coded on the basis of Supplementary data 3. PCI = pre-operative cognitive impairment; METS = metabolic syndrome; CID = clinically important difference;
RCI = reliable change index.
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cognitive impairment (Debess et al., 2009; Dijkstra and Jolles,
2002). However, cognitive tests are usually performed in a con-
trolled environment. It could be that only a substantial impairment
of information processing and attention leads to a decline in test
performance under these circumstances. Perhaps patients with
limited impairment only experience these problems when they
have to sustain their attention over a longer period of time com-
bined with a lot of interference, as occurs in daily life. Therefore,
it cannot be excluded that at least a some POCD patients experi-
ence attention problems. Processing speed is decreased in a very
small percentage of patients (1–3%) on the long term (Iohom
et al., 2004; Price et al., 2008; Silverstein et al., 2007; Williams-
Russo et al., 1995). This could be due to the relatively simple char-
acter of these tests.
The large methodological differences in patient characteristics
(Table 1) and methods to determine POCD (Table 2) lead to diverse
study outcomes. Although this could hamper a clear interpretation
of the results, the diversity is informative in itself. It can be inferred
that working memory, encoding and retrieval of long-term mem-
ory, information processing, processing speed, selective attention,
attention shifting and mental ﬂexibility are all sensitive to persist-
ing postoperative decline. The problems experienced by POCD pa-tients are thus not limited to one cognitive domain but are present
over several cognitive functions.
5.2. Brain areas involved in POCD
Table 4 gives an overview of the brain regions involved in the
cognitive functions that may decline after surgery, based on hu-
man imaging studies. The areas possibly involved in POCD include
pre-frontal, frontal, parietal, temporal, occipital, hippocampal,
insular, cingulate, thalamic and cerebellar regions. Most of these
brain areas are not speciﬁcally activated in one cognitive function
but are involved in several functions. For example, the dorsolateral
prefrontal cortex and posterior parietal cortex seem to be involved
in almost all of the neurocognitive domains that are discussed in
this article. An impairment in one of the areas generally involved
in cognitive functioning, could cause the decline in all domains.
However, considering the current hypothesis that neuroinﬂamma-
tion is involved in POCD development, it is more likely that these
impairments are not restricted to one brain area, but affect more
areas, or even the whole brain. Increased levels of inﬂammatory
factors play a role in diseases related to a range of brain areas
and structures (Lucas et al., 2006). Moreover, animal studies have
repeatedly shown neuroinﬂammatory changes in the hippocampus
Table 3
Summary of the cognitive domains and relevant neuropsychological tests that were used to study postoperative cognitive decline after non-cardiac surgery in humans.
Domain Tests Early decline Late decline
Memory (M)
Working memory Digit span 15%a 8–25%a,b,c
Encoding and retrieval of long-term memory Verbal and visual recall and recognition 5–39%a,b,c,d,e,f,g,h 1–30%a,b,c,e,f,g,h,i,j
Attention (A)
Mental ﬂexibility Trail Making Test 4–10%a,b,d,e,g,j 3–16%a,b,d,e,f,j,k
Selective attention Stroop test 10–15%g,h,j 5–6%c,g,h,j
General ECO attention, WMS-R Nog No/Yesg,i
Information processing
Information processing (I) Substitution test 8–14%a,e,f,h,j 1–3%a,e,f,h,j,k
Language processing (L) 4%-15%a,f,g 1–15%a,f,g,i,k
Visuospatial processing (V) 12–25%f 3–19%f,i
The tests have been divided in cognitive domains. These are memory, attention and information processing. The tests that address memory focus on: (1) working memory:
the retention and manipulation of small amounts of information for a short period of time (Baddely et al., 2009; Friedenberg and Silverman, 2006); or (2) long term memory:
encoding and retrieval of information over longer periods of time. The tests that address attention can be divided into tests that measure: (1) mental ﬂexibility: the ability to
shift between tasks or strategies (Moll et al., 2002; Mrak, 2009; Wager et al., 2004; Zakzanis et al., 2005); or (2) selective attention: the ability to selectively focus on that part
of the information that is of importance (Leung et al., 2000; Liotti et al., 2000). Information processing tasks focus on: (1) processing speed: the speed of perception and
information processing (Usui et al., 2009); (2) language processing: the ability to comprehend and form spoken language; or (3) visuospatial processing: the ability to analyse
and organise visual stimuli.
a (Williams-Russo et al., 1995).
b (Grichnik et al., 1999).
c (Hudetz et al., 2011).
d (Steinmetz et al., 2010).
e (Price et al., 2008).
f (Iohom et al., 2004).
g (Rodriguez et al., 2005).
h (Silverstein et al., 2007).
i (Ancelin et al., 2001).
j (Steinmetz et al., 2009).
k (Evered et al., 2011).
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2011a, 2011b; Rosczyk et al., 2008; Terrando et al., 2010; Wan
et al., 2007, 2010). It seems improbable that changes in hippocam-
pal function alone are responsible for all cognitive impairments
seen after surgery (Table 4).
In summary, various brain areas are involved in the neurocogni-
tive functions that deteriorate in POCD. It seems that the mecha-
nisms behind POCD affect the brain in general and this leads to
impairments in several cognitive domains.5.3. Inter-individual variation in POCD development
Large inter-individual differences between patients can be ob-
served in neuropsychological test outcomes after surgery. For
every test there is a small percentage of patients who show a de-
cline in performance, but usually it is not the same patient that
shows a decline on every test. Ancelin et al. (2001), for example,
found that nine days after surgery, 71% of the patients showed
impairments in any combination of the performed tests, while on
each separate test, a maximum of only 45% of the patients showed
a decline. Conversely, the study by Williams-Russo et al. (1995)
showed that, six months post-surgery, only 5% of all patients expe-
rienced a persisting decline on three or more tests, while on each
separate test, there was a considerably higher percentage of pa-
tients that declined in performance. These studies exemplify the
individual variability in cognitive tasks that are affected by POCD.
This phenomenon is further illustrated by a study by Price et al.
(2008). They made a distinction between patients that experienced
impairments in memory function, in executive function or in both
these functions. Of the patients in this study, 14% showed only
memory decline, 8% showed only a decline in executive function,
and 3% showed a dysfunction in both memory and executive func-
tion three months after surgery. These results indicate that the
clinical manifestation of POCD can vary widely between individu-
als and is likely to depend on individual characteristics.6. Potential mechanisms underlying inter-individual variation
Many mechanisms can potentially increase one’s vulnerability
to cognitive deterioration, such as variations in the genetic code,
metabolic and cardiovascular functioning. Since evidence points
towards an inﬂammatory mechanism underlying POCD, it is inter-
esting to consider whether variations in vulnerability to such an
inﬂammatory mechanism can inﬂuence POCD manifestation.
Old age is considered the most important risk factor for POCD
(Dijkstra and Jolles, 2002; Moller et al., 1998; Newman et al.,
2007; Price et al., 2008). Investigating why the elderly are at
greater risk of developing POCD can lead to more insight into fac-
tors that determine the individual vulnerability to this condition.
Neuroinﬂammatory priming and existing neuron degeneration
are two of these factors.
6.1. Vulnerability to neuroinﬂammation
With ageing, changes occur in the mechanisms regulating the
inﬂammatory processes in the brain. Ageing has been associated
with microglial priming in rodents and humans (Dilger and
Johnson, 2008; Frank et al., 2010; Wynne et al., 2009). Under basal
conditions primed microglia cells secrete minimal amounts of
cytokines. However, they are hyper-responsive to secondary stim-
uli and display an increased and prolonged production of inﬂam-
matory factors when activated (Combrinck et al., 2002; Wynne
et al., 2009; Frank et al., 2010). Furthermore, an increased perme-
ability of the BBB has been reported in aged humans as well as ani-
mal models of senescence (Popescu et al., 2009). These processes
make the aged brain both more susceptible and more reactive to
cytokines from the periphery, leading to an exacerbated neuroin-
ﬂammatory response and, consequently, a higher risk of memory
impairment (Dilger and Johnson, 2008; Lucin and Wyss-Coray,
2009; Sparkman and Johnson, 2008). Barrientos and colleagues
(Barrientos et al., 2006, 2009) illustrated this by injecting adult
and aged rats with Escherichia coli. The aged animals displayed
Table 4
Brain areas involved in cognitive functions.
Area Speciﬁc location Working memory Long-term memory Mental ﬂexibility Selective attention Processing speed Language processing Visual processing
Prefrontal Dorsolateral x x x x x
Ventrolateral x x
Inferior x
frontal cortex (general) x x x
Premotor x
Inferior x x
Parietal Cortex (general) x x x
left Posterior cortex x x x x x x
right posterior cortex x x x x x x
Broca’s area x x x
Wernicke’s area x
Occipital Cortex (general) x x x
Temporal Cortex (general) x x x x
Inferior x
Hippocampus x




Schematic representation of brain areas involved in
cognitive functions
The cognitive functions that seem to be affected in POCD are shown. The two left columns show the brain areas and the speciﬁc locations in these areas that have been found to be involved in these functions. A schematic visual
representation is added of the general brain areas that are involved in each cognitive function, based on our literature review. (Andreasen et al., 1995a,b,c; Baddely et al., 2009; Brand and Jolles, 1985; Buckner et al., 1998; Dickerson
et al., 2007; Forn et al., 2009; Friedenberg and Silverman, 2006; Gazzaniga et al., 2002; Leung et al., 2000; Liotti et al., 2000; MacDonald et al., 2000; MacLeod and MacDonald, 2000; Moll et al., 2002; Monchi et al., 2001; Paulesu
et al., 1993; Owen et al., 2005; Smith et al., 1996; Smith and Jonides, 1997; Squire, 1992; Staresina and Davachi, 2006; Sylvester et al., 2003; Usui et al., 2009; Wager et al., 2004; West and Alain, 1999; Williams-Russo et al., 1995;
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associated with increased memory impairment when compared
to young rats. Similarly, it was shown that in aged versus young ro-
dents, surgery leads to increases in microglial activation, IL-1b lev-
els and IL-6 levels, contributing to a decline in cognitive ﬂexibility
(Rosczyk et al., 2008; Tan et al., 2010).
Ageing-associated changes in immune-regulating properties of
astrocytes or T-cells have been proposed to play a role in microglial
priming (Dilger and Johnson, 2008). It could also be that age-re-
lated priming reﬂects the cumulative effects of repeated immune
activations over the lifetime of an individual. The observation of
microglial priming in animal models of neurodegenerative dis-
eases, characterised by chronic or recurrent inﬂammation, sup-
ports this hypothesis (Dilger and Johnson, 2008; van Harten
et al., 2012).
Based on the above, it can be hypothesised that the manifesta-
tion of POCD depends on the susceptibility of the brain to neuroin-
ﬂammatory processes and inﬂammatory priming. General
characteristics of brain areas make some regions more vulnerable
to inﬂammatory insults than others. For example, it is known that
the hippocampus is especially sensitive to the effects of inﬂamma-
tion (Yirmiya and Goshen, 2011), and memory impairment is more
commonly seen after surgery than impairments of executive func-
tions (Price et al., 2008).
Inter-individual differences have been shown for several as-
pects of the neuroinﬂammatory pathways. One example is the
large inter-individual variation in chemokine receptor expression
that has been associated with inﬂammatory activity and tissue
damage in patients with multiple sclerosis (Fox et al., 2008). Sim-
ilarly, the response of microglia to a pro-inﬂammatory stimulus,
which is hypothesised to be a key factor in POCD development,
has been shown to vary between individuals (Meeuwsen et al.,
2005). In line with age-associated priming, these inter-individual
differences may depend on different immune regulatory properties
or exposure to recurrent priming stimuli, such as stress, a diet rich
in fat and simple carbohydrates, inﬂammatory history and alcohol
use (Bilbo, 2010; Bilbo and Tsang, 2010; Hinwood et al., 2011;
Kanoski and Davidson, 2011; McClain et al., 2011; Tynan et al.,
2010).
6.2. Pre-existing neurodegeneration
Ageing has been associated with neuron damage and abnormal-
ities in various brain regions (Shankar, 2010). Imaging studies in
young and older subjects have revealed that during cognitive tasks,
the activation pattern in older subjects is more widely distributed
across brain areas, especially in the frontal regions (Baddely et al.,
2009; Goh and Park, 2009; Stern, 2009). It has been hypothesised
that the increased activation pattern seen with advancing age is
a mechanism to compensate for the reduced cognitive efﬁciency
following neuronal damage (Goh and Park, 2009; Stern, 2009).
In pathological conditions such as Alzheimer’s disease (MRC
CFAS, 2001), a disjunction between brain damage and cognitive
impairment has long been noted. This discrepancy is explained
by cognitive reserve (Nithianantharajah and Hannan, 2009; Stern,
2002). The theory of cognitive reserve holds that the brain can
compensate for brain damage, by using a reserve present within
the brain. The reserve depends on the extent of pre-existing neuro-
nal networks, which is determined by the number of neurons and
synapses, neuronal plasticity and efﬁciency (Nithianantharajah
and Hannan, 2009; Stern, 2009). Individuals with a greater reserve
can sustain more neural damage or neuronal loss before symptoms
of cognitive decline present themselves (Bekker et al., 2010). These
processes may also play an important role in POCD development.
Cognitive reserve can be inﬂuenced by environmental and geneticfactors, such as toxins, ischaemia and neurodegenerative diseases
that can lead to pre-existing neuronal damage. Many of these det-
rimental effects are brain-area speciﬁc. For example, hypertension
has been associated with detrimental changes in the frontal lobe,
whereas Alzheimer’s disease mainly affects the medial temporal
cortex (Buckner, 2004). Another example comes from subjects with
type 2 diabetes. In an MRI study, Gold et al. (2007) demonstrated
that patients with type 2 diabetes exhibit impairment in hippo-
campus-dependent memory functions that coincide with the pres-
ence of hippocampal atrophy.
In contrast to the above, Bekker et al. (2010) showed that pa-
tients with pre-existing memory impairments have a higher risk
of developing executive impairments than memory impairments
after surgery. This seems to suggest that pre-existing damage in
memory function does not make this domain more vulnerable than
other cognitive functions for surgery-induced impairments. How-
ever, the authors themselves indicate that the results are probably
due to ﬂoor effects in the cognitive tests used, i.e. the test can only
measure a deviation from normal cognition but is not sensitive en-
ough to measure an additional cognitive decline when cognitive
dysfunction is already present (Bekker et al., 2010).
In a recent article Murray et al. (2010) demonstrated that mice
with pre-existing hippocampal neuron damage were more vulner-
able than their healthy counterparts, to hippocampal memory de-
cline, but not to non-hippocampal memory decline, after an
inﬂammatory challenge. This indicates that pre-existing neuron
damage may indeed determine the vulnerability to the inﬂamma-
tion-mediated cognitive changes a patient will experience after
surgery. Accordingly, it has been shown that patients who are
likely to have pre-existing neuron damage, are at higher risk of
developing POCD. Patients with metabolic syndrome, mild cogni-
tive impairment and patients who have fully recovered from a
stroke for example, have a higher risk of developing POCD (Bekker
et al., 2010; Hudetz et al., 2011; Monk et al., 2008; Silverstein et al.,
2007).
In summary, the large variability in cognitive dysfunction after
surgery can be caused by inter-individual differences in the sus-
ceptibility of neural networks to surgery-induced deterioration.
This susceptibility may be the result of genetics and environmental
stimuli that inﬂuence the vulnerability for neuroinﬂammation or
cause pre-existing neurodegeneration. Thus genetic factors and life
history determine if and how POCD manifests itself.7. Future perspectives
Research into cognitive deterioration after surgery can be di-
vided in two distinct ﬁelds that seem to have developed in differ-
ent directions (Fig. 1A). In this review we attempted to bridge the
translation gap between these ﬁelds, using existing literature con-
cerning POCD, to gain insights into the cognitive decline that char-
acterises POCD and the brain areas involved. The most important
outcomes are: (1) POCD encompasses a wide range of cognitive
impairments; (2) POCD affects larger areas of the brain; and (3)
individual variation in the vulnerability of neuronal networks
may determine if and how POCD manifests itself. These ﬁndings
indicate that to bridge the translational gap between the clinical
and pre-clinical research on POCD, the condition should be looked
at from another perspective (Fig. 1B). There are two important
changes that should be considered. First, the change from a general
deﬁnition of cognitive decline after surgery to considering the
whole spectrum of cognitive functions and domains involved in
this condition. Second, the change from only comparing group
means, to analysing inter-relationships between cognitive com-
plaints and physical and mental patient characteristics.
AB
Fig. 1. Schematic representation of the current (A) and future (B) perspectives of pre-clinical and clinical POCD research, considering: (1) the research focus; (2) the way of
determining POCD; (3) the period after surgery in which cognition is studied; and (4) the parameters that are included in the study of POCD. Font size indicates the relative
importance of the factors. (A) The underlying mechanism of POCD has primarily been studied in pre-clinical models, while clinical studies have been used to determine the
incidence and risk factors for POCD. This has led to differences in the approach to study POCD. Pre-clinical studies mainly focus on hippocampal dysfunction within one week
after surgery, in which behaviour and levels of inﬂammatory factors in plasma and hippocampal brain tissue serve as parameters. Clinical studies, however, deﬁne POCD as a
decline of more than one SD or 1.96 Z-score on two or more neuropsychological tests that persists for more than one week after surgery. Few of these studies have included
physiological parameters. These differences in research perspectives have led to a translational gap POCD research, which might lead to incomplete or incorrect assumptions
about the underlying mechanisms. (B) Pre-clinical and clinical studies should include inter-individual variation in their research focus to gain insight into the factors that
predispose certain individuals to develop POCD. In addition, clinical studies should include blood parameters and imaging techniques to make the connexion with pre-clinical
physiological outcomes. Furthermore, research on POCD should take the whole spectrum of cognitive changes after surgery into account. To aid translation to the clinical
setting, pre-clinical studies should expand the time frame of their experiments to include cognitive changes that persist for more than one week after surgery.
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For the pre-clinical models of POCD to be effective it should be
possible to adequately translate the pre-clinical ﬁndings to the hu-
man situation. Therefore, these models should take into account all
cognitive functions that may be affected by surgery into account,
rather than focusing on hippocampal functions. In rats and mice,
there is a broad range of behavioural tests available that can be
used to study cognitive performance in several domains. Pre-
clinical models should relate the outcomes of these cognitive tests
to changes in the associated brain areas on a cellular and molecular
level. Moreover, since POCD constitutes persisting impairments,
pre-clinical models should extend their time-frame. It can be ques-
tioned whether POCD occurs in a comparable time frame in ro-
dents and humans, since differences in metabolism and recovery
can be expected between species. Furthermore, humans usually
have a pre-existing ailment or trauma before undergoing surgery,
whereas laboratory animals do not. This might further alter the
time-frame in which POCD occurs. It may, therefore, not be realis-
tic to expect POCD to persist for the same period of time in labora-
tory rodents and human patients. To be able to make a distinction
between sickness behaviour and delirium symptoms versus per-
sisting cognitive problems after surgery, we suggest POCD research
should include measurements of cognitive function for more than
one week after surgery.
In accordance with clinical studies, animal models should take
into account individual variation in test outcomes. Correlating
the test outcomes with factors of interest to the underlying mech-
anism, will lead to valuable insights. This is especially important
when it comes to studying the persisting impairment of POCD,
since this is only seen in a small percentage of individuals, and
group averages are not likely to differ signiﬁcantly. Moreover, by
studying inter-individual variation in POCD, insight can be gained
into factors that predispose individuals to develop POCD or,
conversely, protect an individual from developing the condition.
Additionally, speciﬁc information about the interplay between
risk-factors for POCD, individual vulnerability and cognitive out-
come can be gained from animal models with a known or induced
vulnerability (Murray et al., 2010). Examples are models of neuro-
degenerative diseases, hypertension, or tissue speciﬁc genetically
modiﬁed strains.7.2. Clinical research
Clinical studies should not only focus onwhether POCD is or not,
but also on the separate cognitive test outcomes. A broad spectrum
of cognitive tests should be used to determine which cognitive do-
mains are affected, including tests for at least thememory, attention
and information-processing domains. By using neuropsychological
of which the brain areas involved are known, or by including imag-
ing techniques in the analysis of POCD, additional insight can be
gained into the brain regions affected and the possible use of
compensatory mechanisms.
In addition to considering the whole spectrum of cognitive
impairments, the variation in manifestation of POCD between
individuals should also be taken into account. By analysing infor-
mation about pre-operative cognitive functioning, post-operative
test performance, and the brain function of each individual patient,
patterns can be detected in the development of POCD. These pat-
terns will provide information about the brain areas related to cer-
tain types of cognitive deterioration after surgery. As such, insight
into the mechanisms underlying POCD will be gained. The out-
comes of such studies will provide a rationale on which to base
pre-clinical research models of POCD. Moreover, knowledge of
the cognitive domains affected could be used to develop andoptimise test batteries for POCD thereby improving diagnostic
methods.
Perhaps even more importantly, by relating individual manifes-
tations of POCD to patient history and characteristics, an assess-
ment can be made of the risk factors for each type of cognitive
decline. This knowledge can then be used to develop an individ-
ual-based risk analysis for cognitive deterioration after surgery.
Interventions can then either consist of tackling the factors that in-
crease POCD risk or targeting the pathophysiological mechanisms.8. Conclusion
Historically, the classiﬁcation of a range of cognitive impair-
ments after surgery under the common denominator ‘POCD’ has
enabled researchers to better understand this condition. For diag-
nostic and policy purposes, this common denominator will still
prove very important. However, to truly understand the underlying
mechanisms of postoperative cognitive impairment and to develop
effective intervention strategies, the whole spectrum of cognitive
impairments and individual variation should be taken into ac-
count. For this purpose, true translational research is mandatory.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.bbi.2012.06.004.
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